XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
Total revenues $ 152,069 $ 156,234
Costs and expenses:    
Cost of sales 27,020 18,748
Research and development expenses 2,843 0
Selling, general and administrative expenses 78,638 46,786
Change in fair value of contingent consideration (25,538) 18,687
Amortization of intangible assets 27,527 32,608
Loss on impairment of intangible assets 279,639 0
Restructuring charges 5,476 0
Total costs and expenses 395,605 116,829
(Loss) income from operations (243,536) 39,405
Other (expense) income:    
Debt related expenses (9,918) 0
Interest expense (3,380) (7,961)
Other gain (loss) 2,780 (278)
Total other expense (10,518) (8,239)
Net (loss) income before income taxes (254,054) 31,166
Income tax (expense) benefit (77,888) 78,459
Net (loss) income (331,942) 109,625
Comprehensive (loss) income $ (331,942) $ 109,625
Basic net (loss) income per share (in dollars per share) $ (4.67) $ 2.33
Diluted net (loss) income per share (in dollars per share) $ (4.67) $ 2.03
Shares used in computing basic net (loss) income per share (in shares) 71,031 47,004
Shares used in computing diluted net (loss) income per share (in shares) 71,031 54,669
Product sales, net    
Revenues:    
Total revenues $ 149,451 $ 155,121
Royalties and milestones    
Revenues:    
Total revenues 2,433 2,403
Other revenue    
Revenues:    
Total revenues $ 185 $ (1,290)